Moreover, the prognostic roles of miR-200c and TUBB3 in restoring chemotherapy sensitivity in ovarian cancer is possibly a cell-context dependent (Brozovic et al., 2015). The gene discussed is TUBB3; the disease is ovarian carcinoma.